ROCKWELL MEDICAL, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
ROCKWELL MEDICAL, INC. (RMTI) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2025-08-14
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2024-06-30 was 1.36M shares.
- ROCKWELL MEDICAL, INC. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2023-06-30 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month |
|---|---|---|
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 |
| 2024-06-30 | 1.36M shares 10-Q · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |